|
GB1307271A
(en)
|
1970-06-25 |
1973-02-14 |
Shell Int Research |
Sulphoximine derivatives and their use in herbicidal compositions
|
|
WO2001025220A1
(en)
|
1999-10-07 |
2001-04-12 |
Amgen Inc. |
Triazine kinase inhibitors
|
|
EP1343782B1
(en)
|
2000-12-21 |
2009-05-06 |
SmithKline Beecham Corporation |
Pyrimidineamines as angiogenesis modulators
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
US7291616B2
(en)
|
2001-10-31 |
2007-11-06 |
Cell Therapeutics, Inc. |
Aryl triazines as LPAAT-β inhibitors and uses thereof
|
|
EP1546121B1
(en)
|
2002-07-18 |
2012-08-29 |
Janssen Pharmaceutica NV |
Substituted triazine kinase inhibitors
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
JP2006518381A
(ja)
|
2003-02-07 |
2006-08-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なヘテロアリール置換ピロール
|
|
WO2004078682A2
(en)
|
2003-03-05 |
2004-09-16 |
Irm Llc |
Cyclic compounds and compositions as protein kinase inhibitors
|
|
WO2005026129A1
(en)
|
2003-09-15 |
2005-03-24 |
Gpc Biotech Ag |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
MY169441A
(en)
|
2004-12-08 |
2019-04-11 |
Janssen Pharmaceutica Nv |
2,4, (4,6) pyrimidine derivatives
|
|
NZ555474A
(en)
|
2004-12-17 |
2010-10-29 |
Astrazeneca Ab |
4-(4-(imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
|
|
EP1674470A1
(en)
|
2004-12-22 |
2006-06-28 |
Schering Aktiengesellschaft |
Sulfonamido-macrocycles as Tie2 inhibitors
|
|
EP1674469A1
(en)
|
2004-12-22 |
2006-06-28 |
Schering Aktiengesellschaft |
Sulfonamido-macrocycles as Tie2 inhibitors
|
|
KR101275609B1
(ko)
|
2005-03-30 |
2013-06-19 |
후지필름 가부시키가이샤 |
용액 캐스팅 방법
|
|
EP1710246A1
(en)
|
2005-04-08 |
2006-10-11 |
Schering Aktiengesellschaft |
Sulfoximine-pyrimidine Macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer
|
|
DE102005062742A1
(de)
|
2005-12-22 |
2007-06-28 |
Bayer Schering Pharma Ag |
Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1803723A1
(de)
|
2006-01-03 |
2007-07-04 |
Bayer Schering Pharma Aktiengesellschaft |
(2,4,9-triaza-1(2,4)-pyrimidina-3(1,3)-benzenacyclononaphan-3^4-yl)-sulfoximid derivate als selektive inhibitoren der aurora kinase zur behandlung von krebs
|
|
EP1873159A1
(en)
|
2006-06-21 |
2008-01-02 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted sulphonamido-macrocycles as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
|
EP1870416A1
(en)
|
2006-06-21 |
2007-12-26 |
Bayer Schering Pharma Aktiengesellschaft |
Sulphonamido-macrocycles as tie2 inhibitors
|
|
DE102006041382A1
(de)
|
2006-08-29 |
2008-03-20 |
Bayer Schering Pharma Ag |
Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren
|
|
DE102006042143A1
(de)
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
|
WO2008060248A1
(en)
|
2006-11-15 |
2008-05-22 |
S*Bio Pte Ltd. |
Indole sustituted pyrimidines and use thereof in the treatment of cancer
|
|
CA2672518A1
(en)
|
2006-12-22 |
2008-07-03 |
Novartis Ag |
Organic compounds and their uses
|
|
JP2010514688A
(ja)
|
2006-12-22 |
2010-05-06 |
ノバルティス アーゲー |
インドール−4−イルピリミジニル−2−イル−アミン誘導体およびサイクリン依存性キナーゼ阻害剤としてのその使用
|
|
HRP20151386T1
(hr)
|
2007-03-12 |
2016-02-26 |
Ym Biosciences Australia Pty Ltd |
Fenil aminopirimidinski spojevi i njihova primjena
|
|
JP5566880B2
(ja)
|
2007-04-24 |
2014-08-06 |
インゲニウム ファーマシューティカルズ ジーエムビーエイチ |
プロテインキナーゼの阻害剤としての4,6−二置換アミノピリミジン誘導体
|
|
WO2008129070A1
(en)
|
2007-04-24 |
2008-10-30 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
WO2008129071A1
(en)
|
2007-04-24 |
2008-10-30 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
WO2008132138A1
(en)
|
2007-04-25 |
2008-11-06 |
Ingenium Pharmaceuticals Gmbh |
Derivatives of 4,6-disubstituted aminopyrimidines
|
|
WO2008140420A2
(en)
|
2007-05-15 |
2008-11-20 |
S*Bio Pte Ltd |
Pyrimidine derivatives
|
|
US8530480B2
(en)
|
2007-09-04 |
2013-09-10 |
The Scripps Research Institute |
Substituted pyrimidinyl-amines as protein kinase inhibitors
|
|
WO2009029998A1
(en)
|
2007-09-06 |
2009-03-12 |
Cytopia Research Pty Ltd |
Retrometabolic compounds
|
|
GB0805477D0
(en)
|
2008-03-26 |
2008-04-30 |
Univ Nottingham |
Pyrimidines triazines and their use as pharmaceutical agents
|
|
WO2009132202A2
(en)
|
2008-04-24 |
2009-10-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
NZ602832A
(en)
|
2008-07-14 |
2014-04-30 |
Gilead Sciences Inc |
Fused heterocyclic hdac inhibitor compounds
|
|
US8415381B2
(en)
|
2009-07-30 |
2013-04-09 |
Novartis Ag |
Heteroaryl compounds and their uses
|
|
CA2771568A1
(en)
|
2009-09-04 |
2011-03-10 |
Novartis Ag |
Heteroaryl compounds as kinase inhibitors
|
|
TW201111378A
(en)
|
2009-09-11 |
2011-04-01 |
Bayer Schering Pharma Ag |
Substituted (heteroarylmethyl) thiohydantoins
|
|
WO2011046970A1
(en)
|
2009-10-12 |
2011-04-21 |
Myrexis, Inc. |
Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
|
|
HU0900798D0
(en)
|
2009-12-21 |
2010-03-01 |
Vichem Chemie Kutato Kft |
4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
|
|
EA026917B1
(ru)
|
2010-03-22 |
2017-05-31 |
Лид Дискавери Сентр Гмбх |
Фармацевтически активные производные двузамещенного триазина
|
|
TW201206946A
(en)
|
2010-07-15 |
2012-02-16 |
Bristol Myers Squibb Co |
Compounds for the reduction of beta-amyloid production
|
|
JP2013542967A
(ja)
|
2010-11-17 |
2013-11-28 |
ノバルティス アーゲー |
3−(アミノアリール)−ピリジン化合物
|
|
WO2012066065A1
(en)
|
2010-11-17 |
2012-05-24 |
Novartis Ag |
Phenyl-heteroaryl amine compounds and their uses
|
|
WO2012101066A1
(en)
|
2011-01-28 |
2012-08-02 |
Novartis Ag |
Pyridine biaryl amine compounds and their uses
|
|
JP2014506878A
(ja)
|
2011-01-28 |
2014-03-20 |
ノバルティス アーゲー |
Cdk9阻害剤としての置換ビ−ヘテロアリール化合物およびそれらの使用
|
|
WO2012101065A2
(en)
|
2011-01-28 |
2012-08-02 |
Novartis Ag |
Pyrimidine biaryl amine compounds and their uses
|
|
WO2012101064A1
(en)
|
2011-01-28 |
2012-08-02 |
Novartis Ag |
N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
|
|
WO2012101063A1
(en)
|
2011-01-28 |
2012-08-02 |
Novartis Ag |
N-acyl pyridine biaryl compounds and their uses
|
|
EP2681193B1
(en)
|
2011-03-02 |
2016-01-06 |
Lead Discovery Center GmbH |
Pharmaceutically active disubstituted pyridine derivatives
|
|
US9226929B2
(en)
|
2011-03-02 |
2016-01-05 |
Bayer Intellectual Property Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
WO2012142329A1
(en)
|
2011-04-12 |
2012-10-18 |
Myrexis, Inc. |
Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
|
|
CN102731413A
(zh)
|
2011-04-15 |
2012-10-17 |
上海医药工业研究院 |
一种脲类化合物、其制备方法、其中间体及其应用
|
|
CN103476759B
(zh)
|
2011-04-19 |
2016-03-16 |
拜耳知识产权有限责任公司 |
取代的4-芳基-n-苯基-1,3,5-三嗪-2-胺
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
WO2013037896A1
(en)
|
2011-09-16 |
2013-03-21 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro-pyrimidines
|
|
EP2755948B1
(en)
|
2011-09-16 |
2016-05-25 |
Bayer Intellectual Property GmbH |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
BR112015003655A2
(pt)
|
2012-08-23 |
2017-07-04 |
Virostatics Srl |
composto; uso de um composto; e composição farmacêutica
|
|
JP6277196B2
(ja)
|
2012-10-18 |
2018-02-07 |
バイエル ファーマ アクチエンゲゼルシャフト |
スルホン基を含んでいるn−(ピリジン−2−イル)ピリミジン−4−アミン誘導体
|
|
HK1209414A1
(en)
|
2012-10-18 |
2016-04-01 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
CN105102434A
(zh)
|
2012-10-18 |
2015-11-25 |
拜耳药业股份公司 |
含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
JP6300818B2
(ja)
|
2012-11-15 |
2018-03-28 |
バイエル ファーマ アクチエンゲゼルシャフト |
スルホキシイミン基を含有する4−(オルト)−フルオロフェニル−5−フルオロピリミジン−2−イルアミン
|
|
MA38090B1
(fr)
|
2012-11-15 |
2018-09-28 |
Bayer Pharma AG |
Dérivés de 5-fluoro-n-(pyridin -2-yl)pyridin-2-amines contenant un groupe sulfoximine
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之n-(吡啶-2-基)嘧啶-4-胺衍生物
|
|
EP2941428A1
(en)
|
2013-01-07 |
2015-11-11 |
Vichem Chemie Kutató KFT |
4-pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (plk1) for the treatment of cancer and their use for the treatment of bacterial infections
|
|
CN105492438B
(zh)
|
2013-07-04 |
2018-08-07 |
拜耳医药股份有限公司 |
磺亚胺取代的5-氟-n-(吡啶-2-基)吡啶-2-胺衍生物以及其作为cdk9激酶抑制剂的用途
|
|
US9856242B2
(en)
|
2014-03-13 |
2018-01-02 |
Bayer Pharma Aktiengesellscaft |
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
US9790189B2
(en)
|
2014-04-01 |
2017-10-17 |
Bayer Pharma Aktiengesellschaft |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
|
|
MA39823A
(fr)
|
2014-04-03 |
2018-01-09 |
Janssen Pharmaceutica Nv |
Dérivés de pyridine macrocyclique
|
|
MA39822A
(fr)
|
2014-04-03 |
2018-02-06 |
Janssen Pharmaceutica Nv |
Dérivés de pyrimidine bicycle
|
|
TN2016000435A1
(en)
|
2014-04-11 |
2018-04-04 |
Bayer Pharma AG |
Novel macrocyclic compounds.
|
|
US10717749B2
(en)
|
2015-09-29 |
2020-07-21 |
Bayer Pharma Aktiengesellschaft |
Macrocyclic sulfondiimine compounds
|
|
JP6888000B2
(ja)
|
2015-10-08 |
2021-06-16 |
バイエル ファーマ アクチエンゲゼルシャフト |
新規な修飾された大環状化合物
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
CA3057891A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
EP3601253B1
(en)
|
2017-03-28 |
2021-09-15 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|